GPhC on 2022: Temporary closures, online pharmacy, and 'remarkable resilience'
General Pharmaceutical Council (GPhC) chair Gisela Abbam provides her reflections on 2022 and her hopes for 2023 in the second of our C+Dmas series
The role of pharmacy is more important than ever as so many of us are increasingly relying on pharmacy professionals and pharmacies for advice and care. Pharmacy professionals are providing more clinical services to the public and patients – especially through community pharmacies.
Read more: Removal ‘likely’ – GPhC cracks down on racism with new FtP proposals
With technological advances and digital health, online pharmacy continues to grow to meet the demands of patients and the public. People are increasingly using online pharmacy services to get medicines and treatments and there can be real benefits to this, but there are also significant risks that need to be managed.
Read more: Give GPhC powers to better regulate online and corporate pharmacies, watchdog says
The issue of temporary pharmacy closures has caused concern for many this year, particularly patients, carers, and their families who rely on community pharmacies for medicines and other services.
As the independent pharmacy regulator, we do not have a role in planning or authorising where pharmacies should be located, when they open, or what they offer. However, pharmacy owners and pharmacy professionals should make sure they are meeting our standards at all times, including when managing closures of pharmacies.
We continue to take part in discussions with key bodies across the three countries that we regulate, including the NHS authorities. We know things are quite arduous for everyone working in pharmacy, in all settings.
There is a growing urgency, both in society as a whole and within pharmacy, to tackle all forms of inequality. As a service provider, it is essential that pharmacies create an environment where the safety and welfare of both the team and patients are protected, and work is carried out within the law.
As a regulator we believe that as well as it being a legal and regulatory duty, embedding the principles of equality and human rights in the day-to-day running of a pharmacy is the right thing to do.
Looking ahead to next year, it’s clear to see that things are not slowing down, particularly with new legislation to strengthen pharmacy governance that commenced in December. It means we received new powers to define how the roles of the responsible pharmacist, superintendent pharmacist and chief pharmacist are fulfilled.
As a result, we are engaging extensively with patients and the public, health professionals, the NHS and the wider health sector, to discuss the requirements and expectations around these roles. That engagement will continue next year before we hold full public consultations on any new rules and standards.